Italy seeks to reclassify cannabidiol as a narcotic
The Italian government, led by far-right Prime Minister Giorgia Meloni, is moving forward with a new decree a controversial proposal that aims to reclassify CBD (cannabidiol) as a narcotic, contrary to global and European decisions regarding CBD regulation.
New Government Decree on CBD Oil
The Italian government introduced a new decree yesterday aimed at classifying CBD for oral use as a narcotic. This decree could take effect 30 days after its publication in the Official Journal. However, it may be subject to an appeal by the TAR, the Italian administrative court. The decree follows the established framework by the previous Speranza decree, who had been broken by the Tar in 2023, but includes new opinions from the Higher Institute of Health and the Higher Health Council, suggesting that these institutions now have sufficient scientific evidence to support this classification.
Giacomo Bulleri, a lawyer specializing in this field, spoke on LinkedIn and to DolceVitaOnline.it on the implications of the decree. He describes the situation as «surreal,» especially since a ruling by the TAR on the matter is still pending. Mr. Bulleri believes that the government could have presented its evidence as part of the ongoing legal proceedings, rather than imposing a new decree. He points out that this decision appears to reflect Italy’s determination to classify CBD as a narcotic, despite the clarification from the European Court of Justice according to which it should not be considered as such.
Mr. Bulleri also points out that the new decree includes World Health Organization recommendations (WHO) from 2020. The WHO had advised all member states not to classify CBD-based products—particularly those with a THC content not exceeding 0.2%—as narcotics. This inclusion raises questions about the scientific necessity and proportionality of the government’s decision.
Impact on the Italian CBD Market
The decree specifically targets oral CBD preparations derived from cannabis, while leaving synthetic CBD products and cosmetic applications unaffected, managed by Cosing. This selective approach adds to the complexity and confusion surrounding the regulations. Furthermore, it creates uncertainty regarding the use of CBD in food products, which could put Italy at odds with the European market as a whole.
Mr. Bulleri warns that Italy risks becoming isolated from the common market. By the end of 2024 or early 2025, the European Food Safety Authority (EFSA) is expected to authorize foods containing CBD throughout Europe, if it manages to pull itself out of the The Novel Food Quagmire. If Italy proceeds with this classification, it could become the only European country to classify CBD as a narcotic, which would hinder its commercial and industrial growth, even though it supplies a large portion of European countries with CBD flowers and extracts.
-
Business4 weeks ago
Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in Quebec3 weeks ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in New Zealand3 weeks ago
Chronic Pain: New Zealand Is Testing Cannabis to Improve Sleep
-
Cannabis in France3 weeks ago
Dr. Pascal Douek, a tireless advocate for medical cannabis in France, has died
-
Cannabis in France3 weeks ago
Medical cannabis: The Greens introduce two amendments to accelerate its widespread adoption
-
Cannabis in Spain4 weeks ago
Spain: Medical Cannabis Is Coming to About 50 Hospitals
-
Business4 weeks ago
British patients now have access to THCV-rich cannabis flowers
-
Cannabis in Canada3 weeks ago
A Canadian study reveals the pleasant psychotropic effects of high-dose CBD


DBD
July 8, 2024 at 13 h 24 min
CBD is giving the mafia too much unfair competition. That's not nice.